Bird Flu
Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program
Published in Genetics and Environmental Business Week, September 11th, 2008
Novavax, Inc. (NASDAQ:NVAX) announced favorable results from the second stage of the Phase I/IIa human clinical trial of its pandemic influenza virus-like particle (VLP) vaccine candidate. The vaccine, which does not contain an adjuvant, induced robust neutralizing antibody responses. Novavax's VLP candidate is directed against the H5N1 A/Indonesia/05/2005 avian influenza strain. Avian influenza emerged in humans in Indonesia in 2005 and has caused 135 documented human cases, 81% of which have been fatal. (1)
In this study, the vaccine demonstrated strong neutralizing antibody titers across all three doses tested, exhibiting increasing antibody titers with the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genetics and Environmental Business Week
More Articles from Genetics and Environmental Business Week
- Applied Biosystems
Applied Biosystems Expands Sequencing-based RNA Analysis Solutions Portfolio - BIOTECHNICA
Finalists nominated for the 2008 EUROPEAN BIOTECHNICA AWARD - Breast Cancer
Studies from Genentech, Inc. in the area of breast cancer published - Cancer
Scripps Translational Science Institute Contributes to Discovery of Predisposition Gene for Childhood Cancer - Cancer Gene Therapy
Gene therapy anti-cancer research featured in Scientific American - Central Nervous System Disorders
EVOTEC TO PRESENT EVOlution TECHNOLOGY PLATFORM AT ISMC-2008 - More from this issue of Genetics and Environmental Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
